secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2026-08-03T20:11:12+00:00
Accession:  0001459839-26-000066
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE Q2 revenue up 15.2% to $56.0M; raises FY 2026 revenue guidance to $231M-$233M
--------------------------------------------------------------------------------

- Net loss improved 33.6% to $4.1M ($0.09 loss per share) vs $6.2M loss a year ago.
- Adjusted EBITDA positive at $2.8M, up 178% from $1.0M in Q2 2025.
- U.S. revenue $53.2M (+14.7%); active U.S. physician base grew 19% to 1,715.
- FY 2026 revenue guidance raised to $231M-$233M (15-16% growth); operating expense growth lowered to ~12%.
- Cash and equivalents $145.9M; positive cash from operations of $0.8M in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983926000066/0001459839-26-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983926000066/sibn-20260803.htm
  HTML page:      https://secwatch.observer/filing/0001459839-26-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer